{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:19:02Z","timestamp":1785161942502,"version":"3.55.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The accumulation of protein glycation end products, in addition to the direct impact of hyperglycemia, represents one of the most common pathomechanisms involved in the development of osteoporosis in diabetic patients. This study aimed to evaluate the accumulation of advanced glycation end products (AGEs) in the skin and the thickness of the intima\/media complex (IMT) in patients with type 1 diabetes in relation to bone mineral density.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>The study comprised a group of 132 individuals, including diabetes mellitus type 1 (DM1) patients. The thickness of the IMT complex was evaluated. Bone mineral density (BMD), T-score, and Z-score were assessed using dual-energy X-ray absorptiometry. Skin AGE assessment was performed by AGE-Reader.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The concentration of AGEs in the skin was significantly higher in patients with DM1 and osteopenia in the femoral neck as compared to individuals with diabetes and normal bone mass, as well as with the control group. The thickness of the IMT complex was significantly greater in subjects with diabetes compared to healthy participants, regardless of osteopenia in the femoral neck and L1-L3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with DM1 demonstrated lower BMD in L1\u2013L4 and in the femoral neck compared to those in the non-diabetic group. Patients with type 1 diabetes mellitus and osteopenia did not present a statistically significant increase in the thickness of the IMT complex compare to those with DM1 without osteopenia. Individuals with coexisting DM1 and osteopenia in the femoral neck, but not in L1\u2013L4, presented significantly higher values of skin AGEs than participants with diabetes mellitus without bone mineral disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1695436","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:20:59Z","timestamp":1762492859000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of skin-advanced glycation end products, IMT complex, and bone mineral density in patients with type 1 diabetes"],"prefix":"10.3389","volume":"16","author":[{"given":"Agnieszka","family":"Zawada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Naskret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Grzelka-Wo\u017aniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja E.","family":"Ratajczak-Paw\u0142owska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Rychter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Skoracka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Michalak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Szymczak-Tomczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Zozulinska-Ziolkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Dobrowolska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Krela-Ka\u017amierczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1103403","article-title":"Association between bone mineral density and cardiovascular disease in older adults","volume":"11","author":"Yang","year":"2023","journal-title":"Front Public Health"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2025.112705","article-title":"Association between lipid accumulation products and mortality outcomes in patients with osteoporosis and osteopenia","volume":"201","author":"Liu","year":"2025","journal-title":"Exp Gerontology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11657-025-01575-8","article-title":"Clinical insights into the role of smoking, diabetes, and rheumatoid arthritis in osteoporotic fractures","volume":"20","author":"Hussain","year":"2025","journal-title":"Arch Osteoporosis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-025-07443-y","article-title":"Prevalence and risk factors for osteoporosis in type 1 diabetes\u2014results from an observational study","volume":"36","author":"Starup-Linde","year":"2025","journal-title":"Osteoporos Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2023.06.005","article-title":"Cardiovascular disease in type 1 diabetes, an underestimated danger: Epidemiological and pathophysiological data","volume":"394","author":"Verg\u00e8s","year":"2024","journal-title":"Atherosclerosis"},{"key":"B6","first-page":"69","article-title":"Cardiovascular disease and osteoporosis","volume":"28","author":"Baldini","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.556","article-title":"FRAX underestimates fracture risk in patients with diabetes","volume":"27","author":"Giangregorio","year":"2012","journal-title":"J Bone Miner Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/843505","article-title":"Pathological significance of mitochondrial glycation","volume":"2012","author":"Pun","year":"2012","journal-title":"Int J Cell Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464050-00001","article-title":"Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease","volume":"64","author":"Zieman","year":"2004","journal-title":"Drugs"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051947","article-title":"Regulation of osteoclast function and bone mass by RAGE","volume":"203","author":"Zhou","year":"2006","journal-title":"J Exp Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/126050","article-title":"Excess body fat increases the accumulation of advanced glycation end products in the skin of patients with type 1 diabetes","volume":"29","author":"Zawada","year":"2020","journal-title":"Adv Clin Exp Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2015.01.002","article-title":"Skin autofluorescence is associated with carotid intima-media thickness, diabetic microangiopathy, and long-lasting metabolic control in type 1 diabetic patients","volume":"98","author":"Araszkiewicz","year":"2015","journal-title":"Results Poznan Prospective Study Microvasc Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.20452\/pamw.1025","article-title":"Assessment of skin autofluorescence as a marker of advanced glycation end product accumulation in type 1 diabetes","volume":"121","author":"Samborski","year":"2011","journal-title":"Pol Arch Med Wewn"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-009-0023-2","article-title":"Proinflammatory cytokines and osteoporosis","volume":"7","author":"McLean","year":"2009","journal-title":"Curr Osteoporos Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"New Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1159\/000341216","article-title":"RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-\u03b1","volume":"49","author":"Deuell","year":"2012","journal-title":"J Vasc Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.7.1192","article-title":"Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women","volume":"24","author":"Nicodemus","year":"2001","journal-title":"Diabetes Care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3892\/mmr.2022.12656","article-title":"Advanced glycation end products promote osteoporosis by inducing ferroptosis in osteoblasts","volume":"25","author":"Ge","year":"2022","journal-title":"Mol Med Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2024.100330","article-title":"Understanding the impact of diabetes on bone health: A clinical review","volume":"24","author":"Sharma","year":"2024","journal-title":"Metab Open"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-009-0939-5","article-title":"Urinary levels of pentosidine and the risk of fracture in postmenopausal women: the OFELY study","volume":"21","author":"Gineyts","year":"2010","journal-title":"Osteoporos Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.467","article-title":"Urinary pentosidine improves risk classification using fracture risk assessment tools for postmenopausal women","volume":"26","author":"Tanaka","year":"2011","journal-title":"J Bone Miner Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s40200-024-01515-2","article-title":"Urinary pentosidine as a potential biomarker of impaired bone health: a systematic review and meta-analysis","volume":"24","author":"Shirinezhad","year":"2024","journal-title":"J Diabetes Metab Disord"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2631-7","article-title":"High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control","volume":"25","author":"Neumann","year":"2014","journal-title":"Osteoporos Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2013.00072","article-title":"Bone quality in diabetes","volume":"4","author":"Saito","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/jbmr\/zjae184","article-title":"Long-duration type 1 diabetes is associated with deficient cortical bone mechanical behavior and altered matrix composition in human femoral bone","volume":"40","author":"Emerzian","year":"2025","journal-title":"J Bone Mineral Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11010-007-9557-8","article-title":"Regulation of advanced glycation end product (AGE) receptors and apoptosis by AGEs in osteoblast-like cells","volume":"306","author":"Mercer","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00674","article-title":"Advanced glycation end products and esRAGE are associated with bone turnover and incidence of hip fracture in older men","volume":"103","author":"Lamb","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e70062","DOI":"10.1002\/dmrr.70062","article-title":"Diabetes and bone health: A comprehensive review of impacts and mechanisms","volume":"41","author":"Upadhyay","year":"2025","journal-title":"Diabetes\/Metabolism Res Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2005.07.012","article-title":"Carotid artery intima\u2013media complex thickening in patients with relatively long-surviving type 1 diabetes mellitus","volume":"20","author":"Distiller","year":"2006","journal-title":"J Diabetes its Complications"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/life14121557","article-title":"Age and sex differences in carotid intima-media thickness: A systematic review and meta-analysis","volume":"14","author":"Myasoedova","year":"2024","journal-title":"Life"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0314031","DOI":"10.1371\/journal.pone.0314031","article-title":"Carotid intima-media thickness and risk of atherosclerosis in multiple sclerosis: A cross-sectional study","volume":"19","author":"Najmi","year":"2024","journal-title":"PloS One"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116030","article-title":"Uncovering the shared lipidomic markers of subclinical osteoporosis-atherosclerosis comorbidity: The Young Finns Study","volume":"151","author":"Mishra","year":"2021","journal-title":"Bone"},{"key":"B34","article-title":"Relationship between changes in brachiocephalic arteries and osteoporosis in women with rheumatoid arthritis","volume":"90","author":"Sineglazova","year":"2012","journal-title":"Klin Med (Mosk)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1695436\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:21:00Z","timestamp":1762492860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1695436\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":34,"alternative-id":["10.3389\/fendo.2025.1695436"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1695436","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"article-number":"1695436"}}